A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of IV gallium to improve pulmonary
function as measured by a 5% or greater relative improvement in forced expiratory volume in
one second (FEV1) from baseline to Day 28.
Funding Source - FDA OOPD
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics